@phari.bsky.social
Physician; Cell and Gene therapy; Curious about everything
Reposted
Melphalan 140 mg/m2 is Safe and Effective for Frail and Older Multiple Myeloma Patients With Comparable Rates of Minimal Residual Disease Negativity #mmsm #bmtsm www.clinical-lymphoma-myeloma-leukemia.com/article/S215...
Melphalan 140 mg/m2 is Safe and Effective for Frail and Older Multiple Myeloma Patients With Comparable Rates of Minimal Residual Disease Negativity
MicroabstractOur study evaluated the efficacy and safety of reduced-dose melphalan
(Mel140) versus high-dose melphalan (Mel200) in 233 multiple myeloma patients undergoing
first autologous stem cell t...
www.clinical-lymphoma-myeloma-leukemia.com
March 20, 2025 at 3:27 AM
Melphalan 140 mg/m2 is Safe and Effective for Frail and Older Multiple Myeloma Patients With Comparable Rates of Minimal Residual Disease Negativity #mmsm #bmtsm www.clinical-lymphoma-myeloma-leukemia.com/article/S215...
Reposted
Sobering statistic! From Gallup: ~31 million Americans report they had to borrow an estimated total of $74 billion in the past 12 months to pay for healthcare for themselves/household member. Timely data since Medicaid/Affordable Care Act cuts are being discussed.
news.gallup.com/poll/657041/...
news.gallup.com/poll/657041/...
Americans Borrow Estimated $74 Billion for Medical Bills in 2024
Twelve percent of Americans report borrowing an estimated $74 billion to pay for healthcare expenses last year. More than one-quarter (28%) report being "very concerned" that a major health event coul...
news.gallup.com
March 9, 2025 at 11:34 PM
Sobering statistic! From Gallup: ~31 million Americans report they had to borrow an estimated total of $74 billion in the past 12 months to pay for healthcare for themselves/household member. Timely data since Medicaid/Affordable Care Act cuts are being discussed.
news.gallup.com/poll/657041/...
news.gallup.com/poll/657041/...
Reposted
Dr. Vinod Balachandran, who received the Yvonne Award 2024, was named to The Washington Post’s Next 50
oncodaily.com/blog/243480 @washingtonpost.com
@mskcancercenter.bsky.social
#Cancer #Researcher #Medicine #Health #YvonneAward #Oncology #OncoDaily
oncodaily.com/blog/243480 @washingtonpost.com
@mskcancercenter.bsky.social
#Cancer #Researcher #Medicine #Health #YvonneAward #Oncology #OncoDaily
Dr. Vinod Balachandran, who received the Yvonne Award 2024, was named to The Washington Post's Next 50 - OncoDaily
Dr. Vinod Balachandran, who received the Yvonne Award 2024, was named to The Washington Post's Next 50 / cancer, Memorial Sloan Kettering Cancer Center, MSK,
oncodaily.com
February 16, 2025 at 4:32 PM
Dr. Vinod Balachandran, who received the Yvonne Award 2024, was named to The Washington Post’s Next 50
oncodaily.com/blog/243480 @washingtonpost.com
@mskcancercenter.bsky.social
#Cancer #Researcher #Medicine #Health #YvonneAward #Oncology #OncoDaily
oncodaily.com/blog/243480 @washingtonpost.com
@mskcancercenter.bsky.social
#Cancer #Researcher #Medicine #Health #YvonneAward #Oncology #OncoDaily
Reposted
Dr N Shah from MCW presenting Tandem CD20-19 CAR-T using fresh in/fresh out manufacturing allowing many patients to receive this therapy who otherwise would not qualify @astct.bsky.social #Tandem25
February 14, 2025 at 1:32 AM
Dr N Shah from MCW presenting Tandem CD20-19 CAR-T using fresh in/fresh out manufacturing allowing many patients to receive this therapy who otherwise would not qualify @astct.bsky.social #Tandem25
Reposted
I never tire of seeing these progressively improved pediatric ALL survival curves, which represent one of the most remarkable achievements in all of medicine.
Amazing to see even more improvement with bispecific antibody #immunotherapy presented in the #ASH24 Plenary session. #hematology #leukemia
Amazing to see even more improvement with bispecific antibody #immunotherapy presented in the #ASH24 Plenary session. #hematology #leukemia
December 8, 2024 at 10:16 PM
I never tire of seeing these progressively improved pediatric ALL survival curves, which represent one of the most remarkable achievements in all of medicine.
Amazing to see even more improvement with bispecific antibody #immunotherapy presented in the #ASH24 Plenary session. #hematology #leukemia
Amazing to see even more improvement with bispecific antibody #immunotherapy presented in the #ASH24 Plenary session. #hematology #leukemia
Reposted
NEW: “Eat What You Kill”
Hailed as a savior upon his arrival in Helena, Dr. Thomas C. Weiner became a favorite of patients and his hospital’s highest earner. As the myth surrounding the high-profile oncologist grew, so did the trail of patient harm and suspicious deaths. @davidmcswane.bsky.social
Hailed as a savior upon his arrival in Helena, Dr. Thomas C. Weiner became a favorite of patients and his hospital’s highest earner. As the myth surrounding the high-profile oncologist grew, so did the trail of patient harm and suspicious deaths. @davidmcswane.bsky.social
A Hospital Helped a Beloved Doctor’s Practice Flourish Even as It Suspected He Was Hurting Patients
Hailed as a savior upon his arrival in Helena, Dr. Thomas C. Weiner became a favorite of patients and his hospital’s highest earner. As the myth surrounding the high-profile oncologist grew, so did…
propub.li
December 7, 2024 at 3:00 PM
NEW: “Eat What You Kill”
Hailed as a savior upon his arrival in Helena, Dr. Thomas C. Weiner became a favorite of patients and his hospital’s highest earner. As the myth surrounding the high-profile oncologist grew, so did the trail of patient harm and suspicious deaths. @davidmcswane.bsky.social
Hailed as a savior upon his arrival in Helena, Dr. Thomas C. Weiner became a favorite of patients and his hospital’s highest earner. As the myth surrounding the high-profile oncologist grew, so did the trail of patient harm and suspicious deaths. @davidmcswane.bsky.social